US 11034957
Amyloid precursor protein (APP) RNAi agent compositions and methods of use thereof
granted A61KA61K31/713A61K48/005
Quick answer
US patent 11034957 (Amyloid precursor protein (APP) RNAi agent compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/713, A61K48/005, A61K9/0085, A61P